Clinical Trial Update: The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether adding minocycline impacts relapse after an initial ketamine/minocycline response in major depressive disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• Minocycline (minocycline)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder | Phase 2 | Status: TERMINATED